Tekmira - Xconomy

by in

Entry	Author	Date	Location
Shedding Baggage, Alnylam Turns a Corner	Steve Dickman	02/21/13	Boston
Alnylam, Lawsuit Settled, Announces $125 Million Stock Offering	Catherine Arnst	01/15/13	Boston
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence	Arlene Weintraub	05/26/11	Boston
Navinet and Vitality use Internet for Health, Constellation Gets to Series A, and Other Boston-Area Life Sciences News	Eric Hal Schwartz	08/19/09	Boston
Microsoft Sells Razorfish, EnerG2 Scores Stimulus Funds, Tekmira Teams Up with Alnylam, & More Seattle-Area Deals News	Gregory T. Huang	08/11/09	Seattle
Vulcan’s Biotech Windfall, Tekmira Tackles RNAi Delivery, The $1,000 Genome Debate, & More Seattle-Area Life Sciences News	Luke Timmerman	05/28/09	Seattle
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News	Rebecca Zacks	05/28/09	Boston
Tekmira Tackles RNAi Delivery Challenge, With Alnylam, Roche Putting It to the Test	Luke Timmerman	05/26/09	Seattle
Targeted Genetics Faces Extinction, Cell Therapeutics Unloads Debt, Dendreon Raises $221M, & More Seattle-Area Life Sciences News	Luke Timmerman	05/14/09	Seattle
Tekmira Nabs $50M RNAi Deal	Luke Timmerman	05/11/09	Seattle
Alnylam Pushes First RNAi Drug That Circulates Through Body Into Human Test	Luke Timmerman	12/23/08	Boston
Page 1 of 1

Xconomy National